NYSE:CRD.B
NYSE:CRD.BInsurance

Crawford (CRD.B) Earnings Surge 62.5%, Reinforcing Bullish Profitability Narrative

Crawford (CRD.B) delivered a standout year, with earnings surging 62.5% after several years of declines, and net profit margins improving to 2.5% from 1.6%. Looking ahead, earnings are projected to grow 25.4% per year, well ahead of the broader US market’s expected 16% pace. However, revenue growth is set to trail the market. These results, driven by higher profit and revenue growth, are likely to focus investor attention on the company’s improving profitability and margins. See our full...
NYSE:BLD
NYSE:BLDConsumer Durables

TopBuild (BLD) Margin Decline Challenges Bullish Narrative on Profit Resilience

TopBuild (BLD) posted a net profit margin of 10.8%, down from 11.7% the previous year, while the company’s earnings have grown at an annualized rate of 18% over the past five years. However, recent momentum has slowed, with negative earnings growth reported for the most recent period, and forward-looking expectations point to just 2.5% annual earnings growth and 9.9% revenue growth, both trailing behind US market averages. The stock trades at a price-to-earnings ratio of 20.6x, which is a...
NYSE:SWK
NYSE:SWKMachinery

Stanley Black & Decker (SWK) Profitability Returns, Challenging Bearish Narratives After $525.6M Loss

Stanley Black & Decker (SWK) just turned the corner on profitability after years of declining earnings, reporting a projected earnings growth rate of 30.2% per year that outpaces both its industry and the broader US market. Revenue, however, is forecast to grow at a slower clip of 3.9% per year, trailing the US market’s expected 10.5% gain. The company’s return to profitability comes after a notable one-off loss of $525.6 million over the last twelve months, putting renewed focus on the...
NYSE:NUVB
NYSE:NUVBPharmaceuticals

Nuvation Bio (NUVB) Losses Widen 45%—Profit Hopes Challenged Despite Strong Revenue Growth Forecast

Nuvation Bio (NUVB) posted another year of widening losses, with its net income declining at an average annual rate of 45.2% over the past five years. Still, analysts expect revenue to surge by 51.23% per year, outpacing the broader US market’s average growth of 10.5%. Despite the robust outlook, shares currently trade at $4.83, well below the company’s estimated fair value of $19.43 based on a discounted cash flow model. Profitability remains elusive and margins show no signs of meaningful...
NasdaqGS:MAR
NasdaqGS:MARHospitality

Marriott (MAR) Margin Decline Reinforces Investor Caution Despite Strong Revenue Growth Outlook

Marriott International (MAR) posted a net profit margin of 35.1% for the latest period, down from last year’s 42.1% margin. Earnings growth turned negative after averaging a robust 32.4% per year over the past five years. Looking ahead, the company is forecast to grow earnings at 10.13% annually, which trails the broader US market’s 16%. However, revenue growth projections of 26.2% per year outpace market expectations. Despite strong historical growth, declining margins and a relatively high...
NasdaqGS:CRVL
NasdaqGS:CRVLHealthcare

CorVel (CRVL) Profit Margin Surge Reinforces Bullish Narratives Despite Valuation Concerns

CorVel (CRVL) delivered high quality results in its latest earnings release, reporting a net profit margin of 11.3% compared to 9.6% last year. Over the past year, earnings growth accelerated to 29.2% against a five-year average of 15.3%. This reflects notable momentum and improved profitability that stands out in the company’s recent performance. Investors may see the combination of margin expansion and rapid earnings growth as a strong positive, even as valuation ratios suggest the shares...
NYSE:W
NYSE:WSpecialty Retail

Are Wayfair’s (W) Efficiency Gains Enough to Offset International Headwinds?

Wayfair recently reported third-quarter 2025 earnings, posting net revenue of US$3.12 billion and confirming mid-single-digit year-over-year growth projections for the upcoming quarter despite the closure of its German operations. This performance, driven by the adoption of AI-powered tools, accelerated delivery logistics, and a growing loyalty program, is attributed to Wayfair’s internal business improvements rather than broader market conditions. We’ll explore how this operational momentum...
NYSE:CTVA
NYSE:CTVAChemicals

Did Corteva's (CTVA) Seeds Spinoff and Dividend Shift Its Strategic Investment Narrative?

Corteva, Inc. announced that its Board of Directors has authorized a common stock dividend of US$0.18 per share, payable on December 15, 2025, to shareholders of record at the close of business on December 1, 2025. Alongside anticipation for its upcoming third-quarter earnings and the planned spinoff of its seeds business in 2026, Corteva is sharpening focus on its crop protection segment. We'll explore how the planned seeds business spinoff could influence Corteva's investment case going...
NasdaqGM:GAIA
NasdaqGM:GAIAEntertainment

Gaia (GAIA): Profitability Forecast Improves, Challenging Bearish Narrative After Years of Deepening Losses

Gaia (GAIA) remains in the red, recording unprofitable results with net losses worsening at an average annual rate of 48.7% over the past five years. Despite the ongoing losses, forecasts now point to rapid improvement, with earnings expected to grow by 95.93% per year and a return to profitability within three years. This would outpace most of the market. Meanwhile, revenue growth is set to reach 14.1% annually, which exceeds the predicted 10.5% average across the US market. At a trading...
NasdaqGM:TRNS
NasdaqGM:TRNSTrade Distributors

Transcat (TRNS): Net Profit Margin Slides to 3.8%, Undercutting Bullish Growth Narratives

Transcat (TRNS) reported earnings per share that have grown at an annual rate of 11.8% over the past five years, with profits expected to accelerate further by 22.7% per year over the next three years. Revenue growth is forecast at 7.8% per year, slower than the broader US market's 10.5% pace. The current net profit margin sits at 3.8%, down from 6.6% last year. Shares trade at $62.35, which is well above an estimated fair value of $28.49. The price-to-earnings ratio stands at 51.2x, far...
NasdaqCM:VSTM
NasdaqCM:VSTMBiotechs

Verastem (VSTM): Persistent Losses Challenge Bullish Growth Narrative Despite 55.7% Revenue Forecast

Verastem (VSTM) is on track for standout top-line growth, with revenue forecast to surge 55.7% per year, well ahead of the broader US market’s 10.5% pace. Despite this bullish revenue outlook, the company remains unprofitable and is projected to stay in the red for at least the next three years, as losses have risen by 23.7% per year over the past five years without net margin improvement. Investor focus this quarter will be on whether Verastem can turn strong growth potential into a path...
NYSE:CSR
NYSE:CSRResidential REITs

Centerspace (CSR) Earnings Heavily Influenced by $52.9M One-Off Gain, Stoking Skepticism on Profit Quality

Centerspace (CSR) is forecasting a steep annual earnings decline of 36.6% over the next three years, even as revenue is expected to grow modestly at 2.2% per year, trailing the broader US market’s 10.5% pace. While the company has recently turned profitable, reported net profits were boosted by a one-off gain of $52.9 million. Its average annual earnings have fallen by 16% over the past five years. With growth rates lagging and profit quality impacted by non-recurring items, investors may...
NYSE:ASAN
NYSE:ASANSoftware

Assessing Asana (ASAN) Valuation Following Recent Share Price Decline

Asana (ASAN) shares have drawn fresh attention as investors reassess the stock’s recent performance and the company’s progress over the past year. The conversation focuses on how changing market sentiment shapes near-term expectations for Asana’s outlook and valuation. See our latest analysis for Asana. Asana’s share price has slipped recently, down 6.34% in a single day and off 33.8% year-to-date, reflecting growing caution among investors even as the company continues to show solid top-line...
NasdaqGS:IDYA
NasdaqGS:IDYABiotechs

IDEAYA Biosciences (IDYA): Revenue Forecast to Grow 28.3% Annually, Profit Still Elusive

IDEAYA Biosciences (IDYA) reported a 45.2% per year increase in losses over the past five years and is forecasted to remain unprofitable for at least the next three years. However, revenue is projected to grow at 28.3% per year, notably outpacing the US market average of 10.5%. With robust top-line growth but continuing net losses, the results reflect a company in high-growth mode with persistent profitability hurdles for investors to watch. See our full analysis for IDEAYA Biosciences. Next,...
NasdaqGS:IAS
NasdaqGS:IASMedia

IAS Net Profit Margin Improves, Reinforcing Positive Community Narrative on Earnings Quality

Integral Ad Science Holding (IAS) posted current net profit margins of 7.9%, improving from 6.4% a year ago, while earnings grew 42.9% over the last twelve months. This is an impressive figure, though it remains below the robust five-year average growth rate of 73.5% per year. Looking ahead, analysts project revenue to rise at 10.1% per year and forecast significant earnings growth at 23.1% per year, both pointing to momentum outpacing much of the US market. With margins expanding and growth...
NasdaqGS:AUDC
NasdaqGS:AUDCCommunications

AudioCodes (AUDC) Earnings Growth Surpasses Five-Year Trend, Challenges Pessimistic Long-Term Narrative

AudioCodes (NasdaqGS:AUDC) delivered a 13.4% jump in earnings over the past year, reversing a trend that has seen average annual declines of 18.9% over the past five years. Net profit margin edged up to 5.7% compared to last year's 5%, even as forecasts call for a -6.4% average annual decline in earnings over the next three years. The current setup puts undervaluation in the spotlight as investors weigh whether recent improvements in margins and profitability can last amid muted growth...
NasdaqGM:STIM
NasdaqGM:STIMMedical Equipment

Neuronetics (STIM): Ongoing Losses Challenge Bullish Narratives Despite Forecast 12.1% Revenue Growth

Neuronetics (STIM) is currently unprofitable, with annual losses widening by 10.3% on average over the past five years. Despite no improvement in net profit margin and the expectation that the company will remain unprofitable for at least the next three years, revenue is forecast to climb 12.1% a year, outpacing the broader US market’s 10.5% growth rate. Investors are likely to weigh the company’s above-average growth prospects and relatively attractive price-to-sales ratio of 1.5x against...
NYSE:LTH
NYSE:LTHHospitality

Life Time (LTH) Profit Margin Doubles, Reinforcing Bullish Community Narratives

Life Time Group Holdings (LTH) posted robust earnings momentum, with net profit surging 101.6% year-over-year and profit margins improving to 9.9% from 5.7% the previous year. Investors saw earnings climb 73.2% per year on average over the past five years, while forecasts call for continued double-digit growth. For investors, the company’s steady profit expansion, improving margins, and appealing relative valuation set a strong tone for this earnings cycle. See our full analysis for Life Time...
NYSE:NSP
NYSE:NSPProfessional Services

Insperity (NSP): Net Margin Falls to 0.3%, Undercutting Bullish Growth Sentiment

Insperity (NSP) reported net profit margins of 0.3%, down sharply from 1.8% a year ago, with historical earnings having declined by 9.9% per year over the last five years. Looking ahead, forecasts anticipate a significant rebound, as earnings are projected to grow by 80.7% per year. However, revenue growth is expected at a slower 7% annually, trailing the broader US market’s 10.5%. As a result, investors are weighing recent margin pressure against robust profit growth expectations in the...
NYSE:IT
NYSE:ITIT

Gartner (IT) Margin Decline to 13.7% Challenges Profit Resilience Narrative

Gartner (IT) reported a 19.8% annual earnings growth rate over the last five years, but recent figures reveal net profit margins fell to 13.7% from 17.3% a year ago, with year-on-year earnings now declining. Despite the slowdown in profit growth, earnings are projected to rise 3.2% annually and revenue is forecast to grow 5.2% per year, both trailing broader US market expectations. With three key rewards identified: long-term earnings growth, ongoing profit or revenue expansion, and signs of...
NYSE:BALL
NYSE:BALLPackaging

Ball (BALL): $384 Million Loss Highlights Ongoing Quality and Valuation Concerns vs Bullish Narratives

Ball (BALL) posted mixed results, with revenue forecast to grow at 3.8% per year, lagging well behind the broader US market’s 10.5% annual pace. EPS is expected to rise at 11.4% per year, again trailing the market’s 16% and remaining below levels considered “significant.” While the past year brought a robust 34.6% earnings rebound, this contrasts with average annual declines of 9.1% over five years. Profit margins improved to 5.6% from 4.5% last year, but the period was weighed down by a...
NasdaqGM:SITM
NasdaqGM:SITMSemiconductor

SiTime (SITM): Assessing Valuation as Earnings Approach and Analyst Outlook Brightens

SiTime (SITM) is set to announce its Q3 2025 earnings on November 5. Recent improvements in revenue and earnings projections for the next two years have helped fuel growing optimism among investors. See our latest analysis for SiTime. SiTime’s share price has powered ahead in recent months, rallying over 32% in the last quarter as the company’s momentum returns and investors weigh up stronger revenue outlooks. That lift has translated into a robust 1-year total shareholder return of nearly...
OTCPK:BCTF
OTCPK:BCTFBanks

Bancorp 34 (BCTF) Profitability Rebound Challenges Cautious Views, But Premium Valuation Faces Growth Risks

Bancorp 34 (BCTF) recently returned to profitability, reversing its net profit margin compared to the prior period. Despite this progress, earnings have declined by 7.4% per year on average over the past five years. Its price-to-earnings ratio of 15.6x remains higher than both the US Banks industry average of 11x and the peer average of 11.6x. While the company is recognized for high quality earnings, the higher valuation multiples and lingering risks around future growth may weigh on...
NYSE:NNN
NYSE:NNNRetail REITs

NNN REIT (NNN) Margin Decline Sparks Debate on Profitability Versus Value Narratives

NNN REIT (NNN) reported revenue growth forecasts of 4.5% per year, trailing the broader US market’s 10.5% pace, while earnings are projected to grow 3.3% annually, also behind the US average of 16%. The company’s net profit margin stands at 43.1%, down from 45.6% last year, and after delivering 13.7% annual earnings growth over five years, earnings slipped into negative territory in the most recent period. With the current share price coming in significantly below estimated fair value and a...